Quoin Pharmaceuticals, Ltd. American Depositary Shares
Symbol: QNRX (NASDAQ)
6.93
▼ (-6.55%) -0.485
Company Description:
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Key Stats
- Today's Open: $7.4
- Today's High: $7.48
- Today's Low: $6.925
- Today's Volume: 23.05K
- Yesterday Close: $7.41
- Yesterday High: $7.6659
- Yesterday Low: $7.08
- Yesterday Volume: 46.52K
- Last Min Volume: 0
- Last Min High: $7.021
- Last Min Low: $6.925
- Last Min VWAP: $0
Company Profile
- Name: Quoin Pharmaceuticals, Ltd. American Depositary Shares
- Website: https://www.quoinpharma.com
- Listed Date: 2021-10-28
- Location: KFAR SABA, L3
- Market Status: Active
- CIK Number: 0001671502
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $4.28M
- Round Lot: 100
- Outstanding Shares: 588.17K
- Asset Type: ADRC
RECENT FILINGS FOR QNRX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-08 | 3 | View |
| 2025-08-27 | S-8 | View |
| 2025-08-27 | 8-K | View |
| 2025-08-25 | S-8 | View |
| 2025-08-25 | 4 | View |
| 2025-08-25 | 4 | View |
| 2025-08-25 | 4 | View |
| 2025-08-21 | 8-K | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-07-17 | ARS | View |
| 2025-07-17 | DEF 14A | View |
| 2025-07-08 | 8-K | View |
| 2025-07-07 | PRE 14A | View |
| 2025-06-25 | 8-K | View |
| 2025-06-20 | 8-K | View |
| 2025-06-13 | 4/A | View |
| 2025-06-13 | 4/A | View |
| 2025-06-04 | 8-K | View |
| 2025-06-03 | 4 | View |
Latest News on QNRX